Suppr超能文献

高通量筛选装置的规模下降设备的膜色谱-聚集去除单克隆抗体。

High throughput screening setup of a scale-down device for membrane chromatography-aggregate removal of monoclonal antibodies.

机构信息

Sartorius Stedim Biotech GmbH, Goettingen, Germany.

Department of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

出版信息

Biotechnol Prog. 2020 Nov;36(6):e3055. doi: 10.1002/btpr.3055. Epub 2020 Aug 29.

Abstract

In biopharmaceutical process development, resin-based high throughput screening (HTS) is well known for overcoming experimental limitations by permitting automated parallel processing at miniaturized scale, which results in fast data generation and reduced feed consumption. For membrane adsorber (MA), HTS solutions have so far only been available to a partial extent. Three case studies were performed with the aim of aligning HTS applications for MAs with those established for column chromatography: Process parameter range determination, mechanistic modeling (MM), and scalability. In order to exploit the MA typically features, such as high mass transfer and easy scalability, for scalable high throughput process development, a scale-down device (SDD) for MA was developed. Its applicability is confirmed for a monoclonal antibody aggregate removal step. The first case study explores the experimental application of the SDD developed. It uses bind and elute mode and variations of pH and salt concentration to obtain process operation windows for ion-exchange MAs Sartobind® S and Q. In the second case study, we successfully developed a mechanistic model based on parameters obtained from the SDD-HTS setup. The results proved to validate the use of the SDD developed for parameter estimation and thus model-based process development. The third case study shows the transferability and scalability of data from the SDD-HTS setup using both a direct scale factor and MM. Both approaches show good applicability with a deviation below 20% in the prediction of 10% dynamic breakthrough capacity and reliable scale-up from 0.42 to 800 ml.

摘要

在生物制药工艺开发中,基于树脂的高通量筛选(HTS)通过允许在小型化规模上进行自动化并行处理而闻名,这可以快速生成数据并减少进料消耗。对于膜吸附剂(MA),到目前为止,仅部分程度上提供了 HTS 解决方案。进行了三个案例研究,目的是使 MA 的 HTS 应用与柱色谱法的应用保持一致:过程参数范围确定、机理建模(MM)和可扩展性。为了利用 MA 的高传质和易于扩展等特点,开发了用于可扩展高通量工艺开发的缩尺设备(SDD)。为单克隆抗体聚集物去除步骤确认了其适用性。第一个案例研究探讨了所开发的 SDD 的实验应用。它使用结合和洗脱模式以及 pH 值和盐浓度的变化来获得用于离子交换 MA Sartobind® S 和 Q 的工艺操作窗口。在第二个案例研究中,我们成功地开发了一种基于从 SDD-HTS 装置获得的参数的机理模型。结果证明,使用所开发的 SDD 进行参数估计以及基于模型的工艺开发是有效的。第三个案例研究表明,使用直接比例因子和 MM 可以从 SDD-HTS 装置传输和扩展数据。这两种方法都具有良好的适用性,在预测 10%动态突破容量时偏差低于 20%,并且从 0.42 到 800ml 的可靠放大。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验